These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 9632359)
21. Comparative molecular field analysis of flavonoid inhibitors of the PIM-1 kinase. Holder S; Lilly M; Brown ML Bioorg Med Chem; 2007 Oct; 15(19):6463-73. PubMed ID: 17637507 [TBL] [Abstract][Full Text] [Related]
22. Three-dimensional quantitative structure-activity relationship study for phenylsulfonyl carboxylates using CoMFA and CoMSIA. Liu X; Yang Z; Wang L Chemosphere; 2003 Dec; 53(8):945-52. PubMed ID: 14505717 [TBL] [Abstract][Full Text] [Related]
23. Molecular structures of metabolites and analogues of diethylstilbestrol and their relationship to receptor binding and biological activity. Duax WL; Swenson DC; Strong PD; Korach KS; McLachlan J; Metzler M Mol Pharmacol; 1984 Nov; 26(3):520-5. PubMed ID: 6548545 [TBL] [Abstract][Full Text] [Related]
24. Pharmacophoric search and 3D-QSAR comparative molecular field analysis studies on agonists of melatonin sheep receptors. Marot C; Chavatte P; Morin-Allory L; Viaud MC; Guillaumet G; Renard P; Lesieur D; Michel A J Med Chem; 1998 Nov; 41(23):4453-65. PubMed ID: 9804685 [TBL] [Abstract][Full Text] [Related]
25. A comparative molecular field analysis (CoMFA) study using semiempirical, density functional, ab initio methods and pharmacophore derivation using DISCOtech on sigma 1 ligands. Jung D; Floyd J; Gund TM J Comput Chem; 2004 Aug; 25(11):1385-99. PubMed ID: 15185333 [TBL] [Abstract][Full Text] [Related]
28. QSAR models for binding of estrogenic compounds to estrogen receptor alpha and beta subtypes. Tong W; Perkins R; Xing L; Welsh WJ; Sheehan DM Endocrinology; 1997 Sep; 138(9):4022-5. PubMed ID: 9275094 [TBL] [Abstract][Full Text] [Related]
29. 3D QSAR studies on protein tyrosine phosphatase 1B inhibitors: comparison of the quality and predictivity among 3D QSAR models obtained from different conformer-based alignments. Pandey G; Saxena AK J Chem Inf Model; 2006; 46(6):2579-90. PubMed ID: 17125198 [TBL] [Abstract][Full Text] [Related]
30. Predictive models for GABAA/benzodiazepine receptor subtypes: studies of quantitative structure-activity relationships for imidazobenzodiazepines at five recombinant GABAA/benzodiazepine receptor subtypes [alphaxbeta3gamma2 (x = 1-3, 5, and 6)] via comparative molecular field analysis. Huang Q; Liu R; Zhang P; He X; McKernan R; Gan T; Bennett DW; Cook JM J Med Chem; 1998 Oct; 41(21):4130-42. PubMed ID: 9767648 [TBL] [Abstract][Full Text] [Related]
31. The application of 3D-QSAR studies for novel cannabinoid ligands substituted at the C1' position of the alkyl side chain on the structural requirements for binding to cannabinoid receptors CB1 and CB2. Durdagi S; Kapou A; Kourouli T; Andreou T; Nikas SP; Nahmias VR; Papahatjis DP; Papadopoulos MG; Mavromoustakos T J Med Chem; 2007 Jun; 50(12):2875-85. PubMed ID: 17521177 [TBL] [Abstract][Full Text] [Related]
32. Mapping the binding site of a large set of quinazoline type EGF-R inhibitors using molecular field analyses and molecular docking studies. Hou T; Zhu L; Chen L; Xu X J Chem Inf Comput Sci; 2003; 43(1):273-87. PubMed ID: 12546563 [TBL] [Abstract][Full Text] [Related]
33. Exploring binding mode for styrylquinoline HIV-1 integrase inhibitors using comparative molecular field analysis and docking studies. Ma XH; Zhang XY; Tan JJ; Chen WZ; Wang CX Acta Pharmacol Sin; 2004 Jul; 25(7):950-8. PubMed ID: 15210071 [TBL] [Abstract][Full Text] [Related]
34. Three-dimensional quantitative structure-activity relationship study on cyclic urea derivatives as HIV-1 protease inhibitors: application of comparative molecular field analysis. Debnath AK J Med Chem; 1999 Jan; 42(2):249-59. PubMed ID: 9925730 [TBL] [Abstract][Full Text] [Related]